DUBLIN--(BUSINESS WIRE)--The "Non-invasive Prenatal Testing Global Market Report 2022, By Type, By End User, By Instruments, By Consumables, By Application" report has been added to ResearchAndMarkets.com's offering.
The global non-invasive prenatal testing market is expected to grow from $3.67 billion in 2021 to $4.21 billion in 2022 at a compound annual growth rate (CAGR) of 14.8%. The market is expected to reach $7.34 billion in 2026 at a CAGR of 14.9%.
The non-invasive prenatal testing market consists of sales of non-invasive prenatal testing kits, instruments and related services. Non-invasive prenatal testing kits and equipment are used to diagnose genetic abnormalities, mainly chromosome defects in fetus in first trimester of pregnancy. Non-invasive prenatal testing includes ultrasound detection, fetal cells in maternal blood tests, cell-free DNA in maternal plasma tests and biochemical screening tests.
The main types of non-invasive prenatal testing are consumables, and instruments. Consumables are products that are used up or depleted throughout their use. The various instrument used are NGS systems, PCR instruments, microarrays, ultrasound devices, and others (centrifuges, UV systems, incubators, microscopes) and the different consumables include assay kits and reagents, disposables. The applications involve trisomy, microdeletion, genetics, Rh factor that are used by hospital and diagnostic labs.
Next generation sequencing has increased the throughput, scalability, and speed, and further enables researchers to perform a wide range of applications and study biological systems at a higher level. Next generation sequencing is a platform that has enabled sequencing of thousands to millions of DNA molecules simultaneously. The manufacturers have introduced this technology to reduce the time and money required and optimizes the output to generate results regarding genome, DNA testing.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.
- It traces the market's historic and forecast market growth by geography.
- The Market Characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
- Market segmentations break down market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies.
- Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Report Scope
Markets Covered:
- By Type: Consumables; Instruments
- By End User: Hospital; Diagnostic Labs
- By Instruments: NGS Systems; PCR Instruments; Microarrays; Ultrasound Devices; Others(Centrifuges; UV Systems; Incubators; MicroScopes)
- By Consumables: Assay Kits &Reagents; Disposables
- By Application: Trisomy; Microdeletion; Genetics; Rh factor
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Companies Mentioned
- F. Hoffmann-La Roche AG
- Illumina Inc.
- Laboratory Corporation of America Holdings
- Natera Inc.
- PerkinElmer Inc.
- Quest Diagnostics Incorporated
- Agilent Technologies Inc
- BGI Diagnosis
- Berry Genomics Co. Ltd
- LifeCodexx AG
- Myriad Genetics Inc.
- NIPD Genetics
- Sequenom Inc.
- Annoroad Gene Technology
- Centogene AG
- Counsyl Inc.
- EUROFINS Genoma Group
- Eurofins Scientific
- Next Biosciences
- Premaitha Health Plc
- Ariosa Diagnostics (Roche)
- Premaitha Health
- Beijing Genomics Institute
- Yourgene Health PLC
- GE Healthcare
- Koninklijke Philips N.V.
- Thermo Fisher Scientific Inc.
- Pacific Biosciences of California Inc.
- QIAGEN N.V.
For more information about this report visit https://www.researchandmarkets.com/r/aseyso
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
